Strategic collaboration supports cutting-edge translational research, combining regulatory-grade bench testing with clinical ...

Barings BDC (BBDC) delivered earnings and revenue surprises of +7.69% and +10.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Goldman Sachs BDC (GSBD) delivered earnings and revenue surprises of -5.00% and -3.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Blue Owl Capital's recent Q2 financial report highlights improved portfolio quality and resilience after a successful merger.

Barings BDC (NYSE:BBDC) declares $0.05/share quarterly dividend, in line with previous. Forward yield 2.18% Payable Sept. 10; for shareholders of record Sept. 3; ex-div Sept. 3. See BBDC Dividend ...

Golub Capital BDC Inc (GBDC) reports robust investment returns and portfolio growth, despite facing a muted M&A environment ...

BDC Laboratories says that the Center for Cardiovascular Translational Science will serve as a hub to drive initiatives in device testing and simulation to serve academic, clinical, and industry ...

Q2 2025 Management View Christopher Dale Long, CEO, reported the deployment of $92.4 million in capital during the quarter, generating total and net investment income of $31.7 million and $13.8 ...

Putnam BDC Income ETF, the actively managed BDC ETF, outperforms BIZD with selective investments and strong returns. Learn ...

Palmer Square Capital BDC Inc. (NYSE: PSBD) ("PSBD" or the "Company"), an externally managed business development company, today announced its financial results for the second quarter ended June 30, ...

CAIS, the leading alternative investment platform for financial advisors, today announced the launch of the Solactive CAIS Private Credit BDC Index ("CAISCRED" or "the Index"). CAISCRED, which is ...

Blackstone leader says the portfolio company within the BDC, a loan extended to a Thoma Bravo-backed software firm, "is ...